1. Home
  2. Category
  3. Cancer Type

Liver Cancer

Online Exclusive Article

Cholangiocarcinoma: Treatment, Outcomes, and Nutrition Overview for Oncology Nurses

Susan Acquisto
Renuka Iyer
Lauren M. Rosati
Natasha Pinheirn
Karen Driskill
Kaitlyn Musto
Heidi Lowitzer
Elizabeth Bradley
Lorraine Drapek
CJON 2018, 22(4), E97-E102 DOI: 10.1188/18.CJON.E97-E102
Background: Cholangiocarcinoma is a cancer that arises from the bile ducts inside or outside of the liver. Although it is a rare cancer, cholangiocarcinoma appears to be rising in incidence in the United States and worldwide. Objectives: The diagnosis of cholangiocarcinoma frequently presents with...
0
No votes yet
Read this Article
Article

Symptom Distress in Patients With Hepatocellular Carcinoma Toward the End of Life

Lissi Hansen
Nathan F. Dieckmann
Kenneth J. Kolbeck
Willscott E. Naugler
Michael F. Chang
ONF 2017, 44(6), 665-673 DOI: 10.1188/17.ONF.665-673
Purpose/Objectives: To describe the presence, frequency, severity, and distress of symptoms in outpatients with advanced hepatocellular carcinoma toward the end of life, and the variability in psychological and physical symptom distress between and within patients over time. Design: A prospective,...
4
Average: 4 (1 vote)
Read this Article
Article

Living With Hepatocellular Carcinoma Near the End of Life: Family Caregivers’ Perspectives

Lissi Hansen
Susan J. Rosenkranz
Kathleen Wherity
Anna Sasaki
ONF 2017, 44(5), 562-570 DOI: 10.1188/17.ONF.562-570
Purpose/Objectives: To explore family caregivers’ perspectives of caring for patients with terminal hepatocellular carcinoma (HCC) as patients approached the end of life. Research Approach: Longitudinal, qualitative descriptive design. Setting: Oregon Health and Science University in Portland and...
0
No votes yet
Read this Article
Advanced Practice Nursing Issues

Yttrium-90 Radioembolization as a Palliative Treatment for Liver Tumors: A Case Study

Lisa Maas
CJON 2015, 19(5), 620-622 DOI: 10.1188/15.CJON.620-622
The best chance of cure for patients with liver cancer is surgical removal, but many tumors are too large or invasive. In addition, chemotherapy is frequently unsuccessful in this patient population. A case study is featured involving a patient determined to be a candidate for Yttrium-90...
0
No votes yet
Read this Article
Article

Hepatic Artery Infusion Pump in the Treatment of Liver Metastases

Lisa Parks
Meghan Routt
CJON 2015, 19(3), 316-320 DOI: 10.1188/15.CJON.316-320
Background: Hepatic artery infusion pump (HAIP) use in chemotherapy started in the 1960s as a way to treat liver metastases that were not amendable to locoregional therapy or surgical resection. Because of complications and limited survival benefit, the use of HAIPs fell out of favor. A resurgence...
0
No votes yet
Read this Article

Questions, Concerns or Requests

We're just a click away for assistance.